MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiA

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

December 18, 2024

Study Completion Date

December 18, 2024

Conditions
Chronic Obstructive Pulmonary Disease
Trial Locations (14)

Unknown

Research Site, Blagoveshchensk

Research Site, Kazan'

Research Site, Krasnodar

Research Site, Krasnoyarsk

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Omsk

Research Site, Rostov-on-Don

Research Site, Ryazan

Research Site, Saint Petersburg

Research Site, Ufa

Research Site, Volgograd

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY